Skip to main content

Big problem:

Type 2 is a costly challenge for self-insured employers.

 

Today,
1 in 10
Americans live with diabetes1

Today,
1 in 4
healthcare dollars are spent on people living with diabetes2

Costs,
$413B
for medical care and lost productivity in 20222

Growing to,
$622B
for annual medical and societal costs by 20303

Level2 offers real financial solutions:

 

 

 

The type 2 program that assures employers realize value:

  • 100% of program fees reconciled against actual medical and pharmacy claims savings.
  • If actual value generated is less than paid program fees, Level2 gives back the difference.
  • Employers can add to most UnitedHealthcare administered plans.

Level2 also offers a condition-specific health plan that guarantees savings up front, through assuming risk of the families living with type 2 diabetes.

Great care makes it all possible.

Level2 Specialty Care is an evidence-based clinical program that helps members work to lower glucose to improve type 2 and even pursue what the ADA defines as remission.

Members have access to:

  • A no-cost continuous glucose monitor (CGM) to see glucose in new ways.
  • Virtual care team of doctors, nurse practitioners, nurses and more to build new habits and feel better.
  • Phase based experience to understand what impacts their glucose.

Level2 Specialty Care
affects outcomes.

 

95%

of members with a
starting A1C of >9.0 had clinically significant improvement (>0.5)*
2.5

Average GMI (estimated A1C) improvement of members with a starting A1C of >9.0**
79%

of members with a
starting A1C >7.0 had clinically significant improvement (>0.5)*
“The leading technology and specialized clinical support that Level2 offers is truly a win-win for both the health of our employees with type 2 diabetes and the potential long-term cost savings of our organization.”

Loren Kennedy

Senior VP of Human Resources at World Travel Holdings, a global travel company that adopted Level2.

Ready to see what the Level2 financial solutions could do for you?

Contact Us

  1. 1Centers for Disease Control and Prevention, Type 2 Diabetes, April 2023 (https://www.cdc.gov/diabetes/basics/type2.html accessed 20-Feb-2024) 

  1. 2Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, ElSayed NA, Bannuru RR. Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care. 2024 Jan 1;47(1):26-43. doi: 10.2337/dci23-0085. PMID: 37909353. 

  1. 3Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: Insights from Yesterday, Today, and Future Trends. Popul Health Manag. 2017 Feb;20(1):6-12. doi: 10.1089/pop.2015.0181. Epub 2016 Apr 28. PMID: 27124621; PMCID: PMC5278808. 

  2. *Sam Bacon, Nels Thompson, David Ferrell, Jason Fung; 943-P: Improved Glycemic Outcomes after One Year Among Level2 Members. Diabetes 20 June 2023; 72 (Supplement_1): 943-P. https://doi.org/10.2337/db23-943-P

  3. **2023 ADA Scientific Sessions Poster 943-9_2023, Improved Glycemic Outcomes after One Year among Level2 Members. Presented Saturday, June 24, 2023